graftys
-
Hospitals
Graftys granted key U.S. patent for GRFT-R02, a highly osteogenic biomaterial
Aix-en-Provence, July 6, 2016 – Graftys SA, a French medical device company specialized in the development, manufacturing and commercialization of…
Read More » -
Biologics
Graftys Announces Creation of an International Implant Registry to Follow up Graftys® HBS and Graftys® QuickSet
AIX-EN-PROVENCE, France–(BUSINESS WIRE)–GRAFTYS SA, a company which develops and commercializes biomaterials used in orthopedic surgery, announces that it has recently…
Read More » -
Smith & Nephew Signs Distribution Agreement for Unique Injectable Bone Void Filler With Graftys
MEMPHIS, Tenn., May 24, 2011 /PRNewswire/ — Smith & Nephew Orthopaedics (NYSE: SNN) today announces the signing of a distribution agreement with French…
Read More » -
GRAFTYS SA has received a Request for Designation
GRAFTYS SA has received a Request for Designation (RFD) response from the FDA indicating that its patented technology for the combination…
Read More »